Cargando…
Dysphonia after Bevacizumab Rechallenge: A Case Report
Inhibition of vascular endothelial growth factor (VEGF) signaling, an initiator of tumor angiogenesis, inhibits tumor growth and invasion. Bevacizumab, a monoclonal antibody to VEGF, in common use as an adjunct to standard chemotherapy like irinotecan in advanced colorectal cancer, also affects the...
Autores principales: | Carter, Corey A., Caroen, Scott Z., Oronsky, Arnold L., Oronsky, Bryan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649738/ https://www.ncbi.nlm.nih.gov/pubmed/26600773 http://dx.doi.org/10.1159/000441122 |
Ejemplares similares
-
Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor
por: Carter, Corey A., et al.
Publicado: (2015) -
RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets
por: Carter, Corey A., et al.
Publicado: (2016) -
RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report
por: Brzezniak, Christina, et al.
Publicado: (2016) -
Effect of Rectal Levodopa Administration: A Case Report
por: Vogelzang, Jolanda M.J., et al.
Publicado: (2015) -
Retroperitoneal Schwannoma in the Renal Hilum: A Case Report
por: Kumano, Yohei, et al.
Publicado: (2015)